Twist Bioscience Corporation (TWST)
Nasdaq · Common stock · Biological Products, (no Diagnostic Substances)
As of Oct 21, 2:17 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow TWST in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on TWST and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
TWST at a glance
Key statistics
$9.46B
Market capitalization
- Previous close
- $142.70
- Open
- $138.25
- Day range
- $138.25 – $152.87
- Volume
- 1.39M
- Average volume (30 sessions)
- 2.84M
- Shares outstanding
- 62.71M
- Earnings per share
- $(2.06)
- Price / book
- 21.2
- Price / sales
- 21.9
- Beta (1 year, vs SPY)
- 2.70
Where the price sits in its year
52-week range
65% of the range
- Below the 52-week high
- -31.6%
- Above the 52-week low
- +544.9%
Completed sessions through Oct 20, 2026
Technical snapshot
Below its 50-day average, above its 200-day
- 20-day average
- $165.58-13.8%
- 50-day average
- $148.75-4.1%
- 200-day average
- $84.35+69.2%
Between the conventional 30 and 70 bands.
-5.7%
1 week
-13.9%
1 month
+51.5%
3 months
+349.9%
Year to date
+406.7%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with TWST
TWST on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on TWST.
See the plans →
Every planScreen names like TWST
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on TWST
Put TWST on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on TWST
See whether there is an open premium alert on TWST, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
TWST headlines
- Global Synthetic Antibody Library Market Report 2026: Size and Forecast to 2030 | Capitalize on 12% CAGR and AI Design with Charles River, Twist Bioscience, GenScript and AbCellera
GlobeNewswire Inc. · Oct 12, 2026
- Key Takeaways From Twist Bioscience Analyst Ratings
Benzinga · Jun 28, 2024
- Expert Outlook: Twist Bioscience Through The Eyes Of 6 Analysts
Benzinga · Jun 5, 2024
- Breaking Down Twist Bioscience: 5 Analysts Share Their Views
Benzinga · May 6, 2024
- Analyst Scoreboard: 5 Ratings For Twist Bioscience
Benzinga · Apr 10, 2024
- 4 Analysts Have This To Say About Twist Bioscience
Benzinga · Feb 5, 2024
- Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On Friday
Benzinga · Nov 17, 2023
SEC Form 4, most recent first
Insider filings
Laponis Adam
−2.5K
Chief Financial Officer · Open-market sale
$384.82K · Oct 9, 2026
Leproust Emily M.
−146
Chief Executive Officer, Director · Open-market sale
$30.20K · Oct 5, 2026
Leproust Emily M.
−45
Chief Executive Officer, Director · Open-market sale
$9.34K · Oct 5, 2026
Leproust Emily M.
−1.0K
Chief Executive Officer, Director · Open-market sale
$205.76K · Oct 5, 2026
Leproust Emily M.
−432
Chief Executive Officer, Director · Open-market sale
$87.96K · Oct 5, 2026
Leproust Emily M.
−481
Chief Executive Officer, Director · Open-market sale
$96.80K · Oct 5, 2026
Leproust Emily M.
−1.8K
Chief Executive Officer, Director · Open-market sale
$368.81K · Oct 5, 2026
Leproust Emily M.
−290
Chief Executive Officer, Director · Open-market sale
$59.39K · Oct 5, 2026
About Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
- Exchange
- Nasdaq
- Security
- Common stock
- Industry
- Biological Products, (no Diagnostic Substances)
- Headquarters
- South San Francisco, CA
- Employees
- 979
- Listed since
- Oct 31, 2018
- Website
- twistbioscience.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.